RecruitingNot applicableNCT06373289
46
studies recruiting now
as of 7 Sept 2026
366
studies registered in total
as of 7 Sept 2026
3
countries with a recruiting site
as of 7 Sept 2026
23 Apr 2025
most recent study posted
among recruiting studies
Recruiting trials
RecruitingNCT04278404
Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)
RecruitingNCT06940856
Chloride Imbalance in Preterm Infants
RecruitingPhase 2NCT06915441
Lipid Infusions to Optimize Nutrition Trial
RecruitingNCT06475976
Multidimensional Phenotype Classification in Grade 3 Bronchopulmonary Dysplasia
Showing the 5 most recently updated recruiting studies, as recorded 7 Sept 2026. Live status on each study page.
See all 46 recruiting studiesWhere recruiting studies are running
Countries with at least one recruiting site among the studies above, 7 Sept 2026. Tap a country to search trials there.
Keep watching
Get an email when a new Bronchopulmonary dysplasia study opens.
One email a day at most. Unsubscribe with one click.
Used only for these alerts. Privacy.
Support
Patient organisations
We do not yet list a dedicated organisation for this condition. The directories below are the best route.
About Bronchopulmonary dysplasia
RareTrial does not yet hold a plain-language description of this condition. The most reliable starting point is Orphanet’s expert page, which lists specialist centres, registries and patient organisations.
Treatments being studied
1 approved treatment and 19 in clinical development, from Open Targets (CC BY 4.0). Not medical advice.
Approved: Palivizumab (Synagis)
Phase 3Caffeine (Caffeine component of anoquan)
Phase 3Sodium Chloride (Aqsia (balanced salt soln))
Phase 3Nitric Oxide (Genosyl)
Phase 3Autologous Cord Blood
Phase 3Azithromycin (Azasite)
Phase 3Calfactant (Infasurf)
Phase 3Dexamethasone (Aeroseb-dex)
Phase 3Clarithromycin (Biaxin)
+ 11 more in development
Related conditions
Information, not medical advice. Trial listings are shown as recorded on ClinicalTrials.gov; whether any study is right for you is a decision for you and your clinicians, and eligibility is decided by each research team. Disease information from Orphanet (CC BY 4.0).